Marta Canamero
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: December 01, 2025
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors.
Journal: ESMO open
Published: November 05, 2025
Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.
Journal: Frontiers in immunology
Published: December 08, 2023
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors.
Journal: Science translational medicine
Published: May 10, 2023
Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC).
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: December 28, 2021
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers.
Journal: Theranostics
Published: May 31, 2021
Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance.
Journal: Cancers
Published: May 19, 2021
Biomarker Technologies to Support Early Clinical Immuno-oncology Development: Advances and Interpretation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 24, 2020
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: August 05, 2020
Last Updated: 09/26/2026